Johnson & Johnson commits $500 million investment over four years to help end the epidemics of HIV and TB

Johnson & Johnson announced it has committed to ensuring more than $500 million dedicated to world class research & development and delivery programs over the next four years to accelerate global efforts to eliminate HIV and TB by 2030.